Trends in the Prevalence, Awareness, Treatment and Control of High Low Density Lipoprotein-Cholesterol Among United States Adults From 1999-2000 Through 2009-2010

被引:50
作者
Muntner, Paul [1 ]
Levitan, Emily B. [1 ]
Brown, Todd M. [1 ]
Sharma, Pradeep [1 ]
Zhao, Hong [1 ]
Bittner, Vera [1 ]
Glasser, Stephen [1 ]
Kilgore, Meredith [2 ]
Yun, Huifeng [1 ]
Woolley, J. Michael [3 ]
Farkouh, Michael E. [4 ,5 ,6 ]
Rosenson, Robert S. [6 ]
机构
[1] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Birmingham, AL USA
[3] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA
[4] Univ Toronto MEF, Peter Munk Cardiac Ctr, Toronto, ON, Canada
[5] Univ Toronto MEF, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada
[6] Icahn Sch Med Mt Sinai, New York, NY USA
关键词
US ADULTS;
D O I
10.1016/j.amjcard.2013.04.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Marked increases in the awareness, treatment, and control of high low-density lipoprotein (LDL) cholesterol occurred among United States (US) adults from 1988-1994 to 1999-2004. An update to the Third Adult Treatment Panel guidelines was published in 2004, and it is unknown if these improvements have continued since the publication of these revised treatment recommendations. The aim of this study was to determine trends in the awareness, treatment, and control of high LDL cholesterol among US adults from 1999-2000 to 2009-2010 using nationally representative samples of US adults aged >= 20 years from 6 consecutive National Health and Nutrition Examination Surveys. (NHANES) in 1999-2000 (n = 1,659), 2001-2002 (n = 1,897), 2003-2004 (n = 1,698), 2005-2006 (n = 1,692), 2007-2008 (n = 2,044), and 2009-2010 (n = 2,318). LDL cholesterol was measured after an overnight fast, and high LDL cholesterol and controlled LDL cholesterol were defined using the 2004 updated Third Adult Treatment Panel guidelines. Awareness and treatment of high cholesterol were defined using self-report. Among US adults, the prevalence of high LDL cholesterol did not change from 1999-2000 (37.2%) to 2009-2010 (37.8%). Awareness of high LDL cholesterol increased from 48.9% in 1999-2000 to 62.8% in 2003-2004 but did not increase further through 2009-2010 (61.5%). Among those aware of having high LDL cholesterol, treatment increased from 41.3% in 1999-2000 to 72.6% in 2007-2008 and was 70.0% in 2009-2010. Among US adults receiving treatment for high LDL cholesterol, the percentage with controlled LDL cholesterol increased from 45.0% in 1999-2000 to 65.3% in 2005-2006 and had decreased slightly by 2009-2010 (63.6%). In conclusion, high LDL cholesterol remains common among US adults. Additional efforts are needed to prevent high LDL cholesterol and increase the awareness, treatment, and control of high LDL cholesterol among US adults. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:664 / 670
页数:7
相关论文
共 9 条
[1]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[2]   Trends in Lipids and Lipoproteins in US Adults, 1988-2010 [J].
Carroll, Margaret D. ;
Kit, Brian K. ;
Lacher, David A. ;
Shero, Susan T. ;
Mussolino, Michael E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (15) :1545-1554
[3]   Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate [J].
Coresh, J ;
Astor, BC ;
McQuillan, G ;
Kusek, J ;
Greene, T ;
Van Lente, F ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (05) :920-929
[4]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[5]   Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].
Grundy, SM ;
Cleeman, JI ;
Merz, CNB ;
Brewer, HB ;
Clark, LT ;
Hunninghake, DB ;
Pasternak, RC ;
Smith, SC ;
Stone, NJ .
CIRCULATION, 2004, 110 (02) :227-239
[6]   Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among US adults [J].
Hyre, Amanda D. ;
Muntner, Paul ;
Menke, Andy ;
Raggi, Paolo ;
He, Jiang .
ANNALS OF EPIDEMIOLOGY, 2007, 17 (07) :548-555
[7]   Trends in statin use and low-density lipoprotein cholesterol levels among US adults: Impact of the 2001 National Cholesterol Education Program guidelines [J].
Mann, Devin ;
Reynolds, Kristi ;
Smith, Donald ;
Muntner, Paul .
ANNALS OF PHARMACOTHERAPY, 2008, 42 (09) :1208-1215
[8]  
Moser A, 2010, J AM OSTEOPATH ASSOC, V110, P331
[9]  
National Center for Health Statistics, 2007, NAT HLTH NUTR EX SUR